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Background: In 2009 two randomised cluster trials took place to assess the introduction of the Italian Version of
the Liverpool Care Pathway in hospitals and hospices. Before and after data were gathered. The primary aim of this
study is to evaluate the feasibility of using a combination of assessment methods aimed at different proxy
respondents to create a means of measuring quality of care at the end of life. We also aim to explore whether
there are differences in response to this approach between the hospice and hospital inpatient settings.
Methods: A retrospective design was used. Eligible deaths were traced through death registries, and proxies were
used to give information. Four procedures of assessment were used to measure different dimensions. Feasibility
was assessed through compliance and adherence to the study instruments, and measured against standards
derived from previous after-death studies. The proxy caregiver’s rating of the study tools was also measured, to
gauge feasibility and effectiveness. All consecutive cancer deaths that occurred in the study period were eligible.
In both trials, deaths were excluded if the patient was a relative of hospital/hospice staff. 145 patients were
recruited from the Hospital setting, and 127 from Hospice.
Results: A high proportion of non-professional caregivers were interviewed – in both hospital (76.6%) and hospice
(74.8%). There was no significant difference in the median number of days in each setting. 89.0% of hospital
patients’ GPs and 85.0% of hospice patients’ GPs were interviewed. Care procedures were recorded in all hospice
cases, and were missing in only 1 hospital case.52.7% of Hospital patients’ relatives and 64.12% Hospice relatives
were assessed to have been caused a low level of distress through the study.
Conclusions: The data shows high levels of compliance and adherence to the study instruments. This suggests
that this approach to assessing quality of care is feasible, and this coupled with low levels of distress caused by
the study instruments suggest effectiveness. There were no substantial differences between the hospice and
hospital settings.
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Research assessing the quality of care at the end of life is
complicated by a number of methodological and ethical
issues, and suitable methods must be found to build a
strong evidence base to support the foundation of effective
palliative care [1] Research focused on the dying phase* Correspondence: e.west@vumc.nl
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unless otherwise stated.(the final days and hours of life) is often found to be more
problematic, and presents some very particular challenges.
Two major issues encountered in this phase concern
the selection of the study population - the dying patients -
and the procedures of the assessment of quality of care.
Study populations may be selected either prospectively
or retrospectively; the prospective approach involves the
identification of an unbiased sample of dying patients
over a specified period of time. The prospective identifi-
cation of study participants in research in the dyingd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for identifying the dying phase [2]. Thus, retrospective
selection of the study population - also called the after-
death approach - has been postulated to be a suitable
alternative.
The assessment of the subjective patient experience
is a major challenge in researching the dying phase.
The prospective approach has the benefit of poten-
tially using the dying patient as the primary source of
information, however dying patients are often the
least able to participate in research [3], may either be
too ill to participate or are likely to have died before
they are able to participate fully [2]. Questions are
also raised concerning stress placed on the patient,
their capacity to answer questions fully and whether
such research is a valuable use of time for patients so
close to death.
In work that relies on the testimonies of informal care-
givers, the identification of these individuals as such can
be problematic - as an individual must self identify as
being the person best informed on the deceased’s final
days of life [4]. This approach is a much more reliable
way of identifying a study population, but using proxy
respondents exclusively may not adequately capture the
subjective experience of the patient. Recall bias may also
unduly influence the validity of information collected.
Some studies have demonstrated that the retrospective
approach is effective in evaluating concrete, observable
phenomena [5], but less so in measuring the qualitative
patient experience [6-8].
However, multiple assessments are possible using
the retrospective approach, as the a number of persons
involved with the deceased, such as family and profes-
sional staff, ancillary staff etc. can be traced through the
final place of stay. This is particularly suited to the multi-
disciplinary nature of palliative care, where measuring the
scope of care with a single scale can be difficult. Multiple
measures can be amalgamated to provide an overview of
the end of life experience, however this can lead to issues
in identification and corroboration of significant results
[9] A single outcome measuring scale is often inappropri-
ate and runs the danger of failing to adequately assess key
outcomes for patients and their families, yet a multidi-
mensional approach needs to be justified in terms of the
level of burden imposed on patients and their families,
and the feasibility of using a labour intensive research
approach [10].
The primary aim of this study is to evaluate the feasi-
bility of using one particular combination of assessment
methods aimed at different proxy respondents to create
a means of measuring quality of care at the end of life.
We also aim to explore whether there are differences in
response to this approach between the hospice and
hospital inpatient settings.Methods
Design
This is a secondary analysis from two cluster trials. Data
gathered at baseline was analysed to assess quality of
care at the end of life for dying cancer patients and their
families. The tools used in the original study were all
aimed at retrospective analysis, after the death of the
patient. In the original study, written consent was ob-
tained from participants. The trial was approved by the
ethics committee of the National Cancer Institute of
Genoa (Genoa, Italy).
The two cluster trials
In 2009 and 2010, two clinical trials were undertaken to
assess the implementation of the Italian version of the
Liverpool Care Pathway for the Dying Patient (LCP-I)
with the aim of improving the quality of end-of-life care
within hospital wards and hospices. According to the
MRC Framework [11] the trials can be classified as a
randomised phase III and a before/after phase II cluster
trial respectively.
The trial performed in the hospital setting [12,13] was
a randomised cluster trial conducted in 16 hospital
wards in 5 Italian regions, where pairs of wards were
allocated to receive either a modified Liverpool Care
Pathway or standard end-of-life care. The quality of end-
of-life care was evaluated for all eligible cancer deaths in
the 3 months before the randomisation date (baseline
evaluation) and in the six months after the conclusion of
the LCP-I Program in the experimental ward (effective-
ness evaluation). The trial performed within the hospice
setting was conducted in 5 hospices in Liguria. This was
a before-after study, in which the quality of end-of-life
care was evaluated in the five hospices for all eligible
deaths in the two months before and in the two months
after the implementation of the LCP-I Program.
Population
For the purpose of this study we used and compared base-
line data from the hospital trial, and pre-intervention data
from the hospice study. In the original studies, the eligibil-
ity criteria included only cancer deaths in the hospital set-
ting, but all deaths in the hospice setting. For the purpose
of this secondary analysis we excluded non-cancer deaths
from the hospice sample. In both trials, deaths were
excluded if the patient was a relative of a member of
hospital/hospice staff.
Setting
5 Ligurian hospices and 16 general medical wards in hos-
pitals across five Italian regions were studied. The number
of beds in the hospice setting ranged between 8–18, with
between 1–5 doctors and 4–9 members of nursing staff.









Figure 1 Process and sequence of data gathering.
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15–44 members of nursing staff.
Standard of comparison
Feasibility was measured through compliance and adher-
ence to the study tools. In order to provide a standard to
measure this against as a measure of effectiveness, we
took guidance from previous studies [14] that utilised an
after-death approach. To reach a level of compliance
that could determine feasibility we looked to identify
and make contact with at least 95% of caregivers and
secure an interview with over 65%. Interviews with
caregivers should have taken place between 2–4 months
after the death of the patient; with face-to-face interviews
comprising at least two thirds of all interviews performed.
We looked for a response rate of at least 75% from GPs to
requests for interview, and expected 100% of care proce-
dures to be recorded.
Procedures of assessment
In both settings, the procedures of assessment in the
original studies were the same.
A clinical chart review was undertaken by medical staff
at the place of death, providing a record of therapeutic
and medical interventions in the final three days of life.
From this, the patient’s GP was contacted by researchers
to answer questions on the quality of communication be-
tween themselves and the ward or hospice professionals.
Both clinical charts and GPs were consulted to identify
the non-professional caregiver - defined as the person
who was closest to the patient during his/her last week of
life in hospital or hospice. An independent interviewer,
trained by the research team, contacted the identified
caregiver and an interview was then arranged. The prefer-
ence was for a face-to-face interview, but if this was not
feasible a telephone interview took place. A professional
with expertise in palliative care performed all interviews
(Figure 1).
Caregiver interview
The quality of end-of-life care provided to the patients
and their families was evaluated by means of a modified
version of the Toolkit After-Death Bereaved Family
Member Interview [15] a semi-structured interview ad-
ministered to a proxy interviewee. The interview was
planned for 2–4 months after the patient’s death, though
if this time scale could not be met the interview was per-
formed outside these parameters. The interview focused
on the patient’s last week of life (or less for those with
shorter hospital or hospice stays). The Toolkit instru-
ment investigates whether physical comfort and emo-
tional support are provided to the dying patient, whether
shared decision making is promoted, if care is focused
on the individual, whether the needs of family membersare met and if satisfactory coordination of care is
achieved.
The modified version of the instrument included seven
scales (1) Informing and making decisions, (2) Advance
care planning, (3) Respect, dignity and kindness, (4) Fam-
ily emotional support, (5) Coordination of care, (6) Family
self-efficacy (7) and the Overall rating of patient-focused,
family-centred care. Added to this were three symptom
scales (pain, breathlessness and nausea-vomiting) from
the Italian version of the ‘VOICES’ questionnaire [14] for
evaluating pain, breathlessness and nausea and vomiting.
At the end of the interview, the interviewer evaluated
the quality of the information provided and the emo-
tional impact of the interview on the non-professional
caregiver by responding to 4 questions, answered on a
Likert scale.
GPs interview
The quality of communication between ward or hospice
professionals and patient’s GPs was evaluated by means
of a semi-structured telephone interview, which took
place after the patient’s death. Two questions enquired
as to whether the GP was informed by the hospital/hos-
pice about the dying phase and the death of the patient
respectively. A third question explored whether the GP
was aware of the terminal status of the patient.
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A standardised document for the recording of diagnostic
and clinical procedures and drugs administered in the
last 3 days of life was created. Nurses or physicians from
the research team completed the document after the
patient’s death.Ethics and privacy
It is important to note that the feasibility of this study is
measured from the viewpoint of the Italian setting,
where the study was originally situated. Differences cross-
culturally in managing ethical and privacy concerns must
be taken into account. The hospital cluster trial [12]
received ethical approval from the Ethics Committee of
the National Cancer Research Institute of Genoa (Italy) on
September 14th 2009 (Reference: CCP09.001) and subse-
quently from the six Local Ethical Committees where the
hospitals were allocated. The hospice cluster trial re-
ceived ethical approval from the Ethics Committee of
the National Cancer Research Institute of Genoa (Italy) on
July 5th 2010 (Reference: CCP10.001) and subsequently
from the four Local Ethical Committees where the
hospices were allocated.
Studies concerning the dying phase can be subject to
particular concern from ethics committees due to the
perceived vulnerability of patients and carers involved
[16]. However, this particular study did not seek to elicit
information from patients, and aimed to merely assess
the feasibility of the investigation methods used in the
studies described.
The tracing of informal caregivers through the de-
cedent’s GP, as performed in the Italian setting, may
be difficult to replicate in other countries and an alterna-
tive solution to trace relatives would need exploring.Data analysis
Feasibility was analysed through investigating compliance
and adherence to the study instruments. The data gath-
ered was compared between the two settings, and against
the expected compliance and adherence levels derived
from the PRISMA and ISDOC studies [14], which also
used the after-death approach.
Compliance to the Toolkit After-Death Bereaved Family
Member Interview, the ancillary 4 questions for interviewer
evaluation and GP’s interviews was assessed, alongside
adherence to the retrospective chart review. Adherence
was also measured through assessing how closely the
study instruments were utilised in accordance with the
original terms suggested in the study protocol; with regard
to variables such as timing and mode of interview.
The Pearson’s Chi-squared test was applied to as-
sess heterogeneity between the samples for nominal
and ordinal data, and Mann–Whitney non-parametricheterogeneity tests are to be used for continuous variables.
IBM SPSS Statistics (version 19) was used for all analyses.
Results
The two trials recruited 272 deaths (145 from hospital and
127 from hospice). Four cases were excluded because the
patients were relatives of a member of staff (all from the
hospital setting). In addition, four non-cancer deaths were
excluded from the hospice sample.
Table 1 shows patient and care characteristics for each
setting. There were demographic differences between
the two populations in terms of gender – 69.0% male in
hospital, and 55.1% male in hospice (P = 0.019), level of
education - almost double the number of hospice patients
having had over nine years of education compared to hos-
pital patients (p = 0.005) and marital status – around a
third of hospital patients classed as single, and half of
hospice patients (P = 0.011) (Table 1).
Final stay characteristics also showed differences be-
tween hospital and hospice. A major difference between
settings was where the patient was referred from, with
over 90% of hospital patients having been referred from
home, compared with under half of hospice patients
(P = <0.001). Primary disease also had marked differences,
the biggest differences being found between genitourinary
tumours, under 10% of hospital patients and almost 20%
of hospice and haematological tumours which comprised
over 15% of hospital patients primary illness, but less than
6% of those in hospice (P = 0.003). Length of stay differed
significantly between settings, with a median of 7 days in
hospital and 11 in hospice (P = 0.008).
There were no significant differences in the caregiver
population between settings.
A high proportion of non-professional caregivers were
identified and interviewed. There were no significant dif-
ferences (P = 0.630) between hospital (76.6%) and hospice
(74.8%). Over 70% of caregiver interviews were performed
“face to face”, with no significant difference by setting
(P = 0.186). In both settings most face-to-face interviews
were performed in the home of the caregiver - 56.3% of
hospital caregivers and 42.1% of hospice (P = 0.029). In
the hospital setting, the range of days between the death
of the patient and the interview being performed was
48 – 234, in the hospice setting this was 61 – 244.
There was no significant difference in the median number
of days in each setting (Table 2).
89.0% of hospital patients’ GPs and 85.0% of hospice
patients’ GPs were interviewed. A significantly (P < 0.001)
higher proportion of GPs of hospice patients (90.7%) as
compared to GPs of hospital patients (69.5%) were infor-
med about the terminal phase of disease of their patients.
(Table 2).
Care procedures were recorded in all hospice cases,
and were missing in only 2 hospital cases.
Table 1 Demographic characteristics of cancer patients
and their caregivers in the two settings
Hospital N = 145 Hospice N = 127 P-value
n. % n. %
Age (mean, range) 76 (46–96) 73 (43–96) .238
Gender
Male 100 69.0 70 55.1
Female 45 31.0 57 44.9 .019
Education (years)
9-13 21 18.3 35 36.4
6-8 26 22.6 23 24.0
0-5 68 59.1 38 39.6 .005
Unknown 30 31
Marital status
Single 42 32.3 55 48.2
Married 88 67.7 59 51.8 .011
Unknown 15 13
Referred from
Home 123 87.9 51 40.2
Nursing home 7 5.0 8 6.3
Hospital 10 7.1 68 53.5 <.001
Unknown 5 -
Primary tumour
Digestive system 45 31.0 41 32.3
Respiratory system 40 27.6 30 23.6
Genitourinary system 14 9.7 24 18.9
Haematological 27 18.6 7 5.5
Breast 8 5.5 5 3.9
Others 11 7.6 20 15.7 .003
Days in ward/hospice
(median, range)
7 (1–63) 11 (1–261) .008
CAREGIVER
Age (mean, range) 55 (24–91) 54 (25–81) .779
Gender
Male 52 36.4 46 36.2
Female 91 63.6 81 63.8 .981
Unknown 2
Relationship partner 40 28.4 37 29.1
Child 78 55.3 61 48.1
Other 23 16.3 29 22.8 .339
Unknown 4 -
Education (years)
9-13 55 51.8 61 64.2
6-8 36 34.0 28 29.5
0-5 15 14.2 6 6.3 .101
Unknown 39 32
Notes: Category “single” include widowed, divorced and separated.






n. % n. %
Proxy interview
Performed interviews 111 76.6 95 74.8
Not found 8 5.5 4 3.1
Not present 1 0.7 - -
Refused 23 15.9 26 20.5
Other 2 1.4 2 1.6 .630
Death – interview interval
< 2 months 64 55.2 61 64.2
2 – 4 months 38 32.8 32 33.7
> 4 months 14 12.1 2 2.1 .023
Length of interview
(minutes); median (range)
40 (10–120) 35 (15–90) .105
Mode of interview
Face to face 80 72.1 76 80.0
By telephone 31 27.9 19 20.0 .186
Not performed 34 32
Interview setting (for face
to face interviews)
Home 45 56.3 32 42.1
Health service 17 21.2 17 22.4
Caregiver work place 13 16.3 10 13.2
Other 5 6.2 17 22.4 .029
GP Interviews
Performed interviews 129 89.0 108 85.0
Not found 14 9.7 14 11.0
Not present - - 1 0.8
Refused 2 1.4 1 0.8
Other - - 3 2.4 .285
Death – interview interval
(days); median (range)
86 (27–365) 103 (29–168) .008
GP aware of terminal status
Yes 89 69.5 98 90.7
No 39 30.5 10 9.3 <.001
Unknown 17 19
Care procedures
Charts reviewed 143 98.6 127 100 .184
Notes: Unless otherwise specified n. (%).
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the caregiver was well informed on the patient’s status in
the last days of life. There was a similar outcome between
settings, with over three quarters of hospital and hospice
caregivers reported to have a high level of understanding
on this subject – defined as scoring “a lot” or “completely”
on the Likert scale (.108). A similar amount of respondents
Table 3 Interviewer’s assessment of level of information
of the caregivers and distress potentially caused by the
interview
Hospital Hospice P-value
n =110 n = 92
% %
Was the caregiver well informed
on the status of the patient in
the last days of life?
Not at all NA NA
A little 9.1 1.1
Somewhat 12.7 17.4
A lot 45.5 47.8
Completely 31.8 33.7 .108
I don’t know 0.9 -
What is the interviewee’s level
of comprehension of the
questions asked in this interview?
Not at all - -
A little 1.8 2.2
Somewhat 21.1 19.6
A lot 39.4 40.2
Completely 36.7 38.0 .915
I don’t know 0.9 -
Has the caregiver provided
complete and reliable answers
on the patient’s situation?
Not at all - -
A little 4.6 2.2
Somewhat 28.4 16.3
A lot 44.0 56.5
Completely 22.9 25.0 .127
I don’t know - -
Has the administration of this
interview caused distress to
the caregiver?
Not at all 12.7 16.3
A little 40.0 47.8
Somewhat 32.7 26.1
A lot 9.1 6.5
Completely 3.6 3.3 .549
I don’t know 1.8 -
NOTE: NA is not applicable.
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(.915), and assessment of whether their answers were
deemed to be “complete and reliable” (.127).
52.7% of Hospital patients’ relatives and 64.1% Hospice
relatives were assessed by the interviewer to have been
caused a low level of distress through the modified
TOOLKIT interview (an answer of “not at all” of “a little”to the original question). A large proportion were judged
to be “somewhat” distressed (32.7% and 26.1% respect-
ively). However, this does leave 12.7% of the relatives of
hospital patients and 9.8% of the relatives of hospice
patients being judged as having a high score on the
distress related scale.
Strengths and limitations
The results show a high level of compliance and adher-
ence to all measurement tools in each environment. Com-
parison between the two settings showed that, though the
populations were not identical in terms of demographics
and characteristics of the final stay, results according to
the study instruments were comparable.
However the results do also cast light on possible prob-
lems within the study. The results concerning timing of
interviews in Table 2 suggest that the ideal time frame set
out in the protocol for administering interviews to care-
givers and GPs deserve further investigation and con-
sideration. Published literature calls attention to issues
surrounding ideal timing of research; in order to achieve a
balance between maximising the accurate recall of events,
maximising the response rate and (if the respondent is a
non-professional caregiver) minimising any potential dis-
tress an optimum timing must be sought. Although find-
ings from research in this area differ, administering an
interview 2–3 months after the patient death seems to be
the most widely accepted guideline from the research
literature [3]. Changes to this could be explored in light of
reducing the circa 10% of patients in each group who
scored a high level of distress on the interviewer’s assess-
ment of the Toolkit interview.
The use of proxy respondents is a limitation intrinsic to
this study and results must be interpreted with the know-
ledge that the main sources of information are proxies
and not patients, with all that this entails.
Discussion
This study aimed to address this issue by exploring end
of life care through a multi-faceted means of assessment,
as well as comparing the results of assessment between
the hospital and hospice settings – comparing results
against previous studies that utilised the after-death ap-
proach to assess effectiveness of the research tools. We
looked to assess the feasibility of using this particular
combination of research tools to provide a nuanced
assessment of the end-of-life experience as assessed
by proxy respondents.
Existing literature exploring the after death approach
has commented on the role and reliability of proxy
respondents. Proxy respondents (non-professional care-
givers, GPs) are often used in research, though even
when the primary caregiver is identifiable research has
demonstrated that the accuracy of proxies’ evaluation
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caregiving [17], and that discrepancies between patients
and proxies increase with their involvement in day-to
day care [18,19]. On the other hand, some findings
underline that proxies living with the patient are better
able to report on the patient’s experience [7].
The tests in this study have shown a higher level of
compliance overall than the ISDOC study that was the
basis of comparison. Two thirds of interviews with care-
givers were performed face to face, and the majority of
those not interviewed face to face were interviewed
by telephone. This study differed from ISDOC in that
though the preferred interview method was face to
face, the option existed to perform a telephone interview
if the caregiver was to refuse the first option. This, along
with allowing interviewees the freedom to choose a loca-
tion for the face to face interview potentially raises the
feasibility of this type of assessment by allowing inter-
viewees to take ownership over the process, and was
developed to combat non-response bias, as explored by
Cassarett et al. [20].
Investigating the use of GPs as a potentially valid
source of information also formed an important part of
measuring the feasibility of this approach. The majority
of GPs were interviewed after initial contact, and provided
information on patients. Though over 30% of the GPs of
hospital patients indicated that they were unaware that
the patient was in the terminal phase of illness, this per-
centage was much lower amongst hospice GPs - who
reported having this knowledge in 90.2% of cases. This
information is important in planning studies that use the
GP as a source of information concerning patients’ end-
of-life care. The way in which GPs were used in the
original study to provide details of the caregiver to be
contacted would be difficult to replicate outside of Italy
due to differing approaches to data protection and patient
privacy. It is also important to note that this may act as a
form of gatekeeping through restricting access to certain
caregivers, or prioritising traditionally important family
members over those who may have participated more in
the caring process. Direct contact with those identified by
the final place of care as being the primary informal care-
giver could avoid such potential bias.
The interviewer’s evaluation of the TOOLKIT interview
also helps us to understand further the concept of feasibility
through providing a snapshot of the understanding of the
caregiver during the interview. According to interviewer
assessment, most caregivers were deemed to have a good
level of information and comprehension of the patient’s
condition at the end of life. In most cases the interviewers
reported low or no distress caused by the interview. These
levels are similar to those found by Koffman et al. [21], who
also highlight the possibility that such interviews may in
fact be beneficial to bereaved relatives.Though it is widely acknowledged that a stronger evi-
dence base is necessary to support palliative care as a
complex intervention, assessing research at the end-of-
life can be a difficult undertaking due to the number
and depth of outcomes measured [12]. A tool that com-
bines a number of respondents on different facets of the
end-of-life experience could help to address this prob-
lem and provide a more nuanced assessment of quality
of care in the dying process.
Conclusions
The data shows high levels of compliance and adher-
ence to all study instruments in the two settings. The
combination of various forms of data collection, from
various sources (caregivers, GPs, clinical documentation)
and the high compliance to all forms of assessment in
both hospice and hospital settings suggests that this ap-
proach for assessing information about quality of care is
feasible. When combined with the interviewers’ assess-
ment on comprehension or question, quality of answers
and distress levels of interviewees results suggest that this
approach is an effective combination of tools to assess
quality of care at the end of life, from an after-death
approach.
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